US5279960A
(en)
*
|
1984-07-05 |
1994-01-18 |
Enzon Corp. |
25 KD coccidial antigen of eimeria tenella
|
US4732974A
(en)
*
|
1986-03-05 |
1988-03-22 |
Mallinckrodt, Inc. |
Metal ion labeling of carrier molecules
|
US5047513A
(en)
*
|
1986-07-10 |
1991-09-10 |
Hoffmann-La Roche Inc. |
Metal chelate resins
|
CA1340522C
(en)
*
|
1987-03-10 |
1999-05-04 |
Heinz Dobeli |
Fusion proteins containing neighbouring histidines for improved purification
|
GB8706599D0
(en)
*
|
1987-03-19 |
1987-04-23 |
Hoffmann La Roche |
Plasmodium falciparum merozoite antigen peptides
|
ES2054769T3
(es)
*
|
1987-11-16 |
1994-08-16 |
Hoffmann La Roche |
Polipeptidos hiv-2 recombinantes.
|
US5780038A
(en)
*
|
1987-11-16 |
1998-07-14 |
Roche Diagnostic Systems, Inc. |
HIV-2 envelope polypeptides
|
JPH084519B2
(ja)
*
|
1987-12-25 |
1996-01-24 |
エフ・ホフマン―ラ ロシュ アーゲー |
ハイブリッド形成用担体およびその調整方法
|
US4927879A
(en)
*
|
1988-02-25 |
1990-05-22 |
Purdue Research Foundation |
Method for solid phase membrane mimetics
|
US4931498A
(en)
*
|
1988-02-25 |
1990-06-05 |
Purdue Research Foundation |
Immobilized artificial membranes
|
US4952321A
(en)
*
|
1988-10-07 |
1990-08-28 |
Brigham Young University |
Process of removing and concentrating desired ions from solutions
|
US5169936A
(en)
*
|
1989-04-14 |
1992-12-08 |
Biogen, Inc. |
Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
|
US5115102A
(en)
*
|
1989-07-21 |
1992-05-19 |
Monsanto Company |
Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices
|
US5780597A
(en)
*
|
1989-12-22 |
1998-07-14 |
Hoffmann-La Roche Inc. |
Monoclonal antibodies to cytotoxic lymphocyte maturation factor
|
US5182369A
(en)
*
|
1990-02-28 |
1993-01-26 |
Monsanto Company |
Method for purifying somatotropin monomers
|
US5136025A
(en)
*
|
1990-04-04 |
1992-08-04 |
California Biotechnology Inc. |
Method to purify basic fibroblast growth factor
|
WO1991015589A1
(en)
*
|
1990-04-09 |
1991-10-17 |
The Upjohn Company |
Improved process of purifying recombinant proteins and compounds useful in such process
|
US5594115A
(en)
*
|
1990-04-09 |
1997-01-14 |
Pharmacia & Upjohn Company |
Process of purifying recombinant proteins and compounds useful in such process
|
US5972337A
(en)
*
|
1990-11-01 |
1999-10-26 |
Cancer Research Fund Of Contra Costa |
46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
|
AU662508B2
(en)
*
|
1990-12-13 |
1995-09-07 |
Pharmacia & Upjohn Company |
Fusion polypeptides
|
WO1992013093A1
(en)
*
|
1991-01-25 |
1992-08-06 |
Sloan-Kettering Institute For Cancer Research |
Antigen recognized by patients with antibody associated cerebellar degeneration, dna encoding same and uses thereof
|
US5439829A
(en)
*
|
1991-01-30 |
1995-08-08 |
Eli Lilly And Company |
Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
|
EP0505151A3
(en)
*
|
1991-03-19 |
1993-04-07 |
Eli Lilly And Company |
Preparation of the penicilline binding protein 2a from staphylococcus aureus 27r, purification and use in a resistant-assay
|
US6602861B1
(en)
*
|
1992-04-16 |
2003-08-05 |
Research Corporation Technologies, Inc. |
Acylated phospholipid drugs
|
EP0583894A3
(en)
*
|
1992-07-29 |
1995-09-06 |
Hybritech Inc |
Method of immobilizing and orienting molecules by use of metal chelating moieties to facilitate atomic force microscopy of proteins and molecular scale manipulation
|
US7070782B1
(en)
*
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
SE9303822D0
(sv)
*
|
1993-11-18 |
1993-11-18 |
Kabi Pharmacia Ab |
Method for purification
|
US5449758A
(en)
*
|
1993-12-02 |
1995-09-12 |
Life Technologies, Inc. |
Protein size marker ladder
|
DE4433980C2
(de)
*
|
1994-09-23 |
1996-08-22 |
Boehringer Ingelheim Int |
Verfahren und Biosensorhit zur Untersuchung der Wechselwirkung von Biomolekülen mittels Oberflächen-Plasma-Resonanz
|
US5837520A
(en)
*
|
1995-03-07 |
1998-11-17 |
Canji, Inc. |
Method of purification of viral vectors
|
US5753206A
(en)
*
|
1995-06-07 |
1998-05-19 |
Immunomedics, Inc. |
Radiometal-binding analogues of luteinizing hormone releasing hormone
|
US20040253246A1
(en)
*
|
1996-02-23 |
2004-12-16 |
Israeli Ron S. |
Prostate-specific membrane antigen and uses thereof
|
ES2108652B1
(es)
*
|
1996-04-19 |
1998-07-16 |
Antibioticos Sa |
Un procedimiento para modificar la enzima 7/3-(4-carboxibutanamido) cefalosporinacilasa y purificarla en un solo paso cromatografico.
|
DK0821006T3
(da)
|
1996-07-26 |
2004-08-16 |
Aventis Pharma Gmbh |
Insulinderivater med öget zinkbinding
|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
US6271000B1
(en)
*
|
1996-12-13 |
2001-08-07 |
Eli Lilly And Company |
Streptococcus pneumoniae gene sequence mraY
|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
AU6020998A
(en)
|
1997-01-08 |
1998-08-03 |
Life Technologies, Inc. |
Methods for production of proteins
|
US5932102A
(en)
*
|
1998-01-12 |
1999-08-03 |
Schering Corporation |
Immobilized metal, affinity chromatography
|
US7026456B1
(en)
*
|
1998-01-23 |
2006-04-11 |
Hoffman-La Roche, Inc. |
Antibodies against human IL-12
|
US6008329A
(en)
*
|
1998-03-06 |
1999-12-28 |
The United States Of America As Represented By The Secretary Of The Army |
Method for purifying cholera toxin
|
AU4187799A
(en)
*
|
1998-05-14 |
1999-11-29 |
Clontech Laboratories, Inc. |
Compositions and methods for protein purification based on metal ion affinity site
|
DE19825447A1
(de)
*
|
1998-06-06 |
1999-12-09 |
Hoechst Marion Roussel De Gmbh |
Neue Insulinanaloga mit erhöhter Zinkbildung
|
US7176298B2
(en)
|
1998-09-25 |
2007-02-13 |
Clontech Laboratories, Inc. |
Polynucleotides encoding metal ion affinity peptides and related products
|
US7449338B2
(en)
*
|
1998-10-02 |
2008-11-11 |
Ischemia Technologies, Inc. |
Tests for the rapid evaluation of ischemic states and kits
|
US6475743B1
(en)
|
1998-10-02 |
2002-11-05 |
Ischemia Technologies, Inc. |
Marker useful for detection and measurement of free radical damage and method
|
US20030215359A1
(en)
*
|
1998-10-02 |
2003-11-20 |
Ischemia Technologies, Inc. |
Tests for the rapid evaluation of ischemic states and kits
|
US20050142613A1
(en)
*
|
1998-10-02 |
2005-06-30 |
David Bar-Or |
Test for the rapid evaluation of ischemic states and kits
|
US7297544B2
(en)
*
|
1998-10-02 |
2007-11-20 |
Ischemia Technologies, Inc. |
Tests for the rapid evaluation of ischemic states and kits
|
US7070937B1
(en)
|
1998-10-02 |
2006-07-04 |
Ischemia Technologies, Inc. |
Marker useful for detection and measurement of free radical damage and method
|
US6479300B1
(en)
|
1999-03-15 |
2002-11-12 |
Millipore Corporation |
Metal loaded ligand bound membranes for metal ion affinity chromatography
|
US6379903B1
(en)
|
1999-10-08 |
2002-04-30 |
Sigma-Aldrich Co. |
Purification of recombinant proteins fused to multiple epitopes
|
WO2001028569A1
(en)
*
|
1999-10-15 |
2001-04-26 |
Canji, Inc. |
Targeted vectors
|
US6521111B1
(en)
|
2000-04-10 |
2003-02-18 |
Invitrogen Corporation |
Methods and articles for labeling polymer gels
|
US6623655B1
(en)
†
|
2000-04-24 |
2003-09-23 |
Sigma-Aldrich Co. |
Metal chelating compositions
|
DE50112379D1
(de)
*
|
2000-08-11 |
2007-05-31 |
Univ Ruprecht Karls Heidelberg |
Fv-konstrukte mit beeinflussbarer affinitat zu einer zu bindenden substanz
|
DE10040179A1
(de)
*
|
2000-08-17 |
2002-02-28 |
Ipk Inst Fuer Pflanzengenetik |
Beeinflussung der Verteilung von Metallen in transgenen Pflanzen
|
US20040180415A1
(en)
*
|
2001-05-15 |
2004-09-16 |
Tchaga Grigoriy S. |
Methods and compositions for protein purification
|
CA2447594A1
(en)
|
2001-06-21 |
2003-01-03 |
Clontech Laboratories, Inc. |
Water-soluble polymeric metal ion affinity compositions and methods for using the same
|
US6902914B2
(en)
*
|
2001-09-28 |
2005-06-07 |
Sigma-Aldrich, Co. |
Recombinant DNA processes using a dNTP mixture containing modified nucleotides
|
US7799561B2
(en)
*
|
2002-06-12 |
2010-09-21 |
Sigma-Aldrich, Co. |
Affinity peptides and method for purification of recombinant proteins
|
US8029803B2
(en)
|
2002-06-20 |
2011-10-04 |
Paladin Labs, Inc. |
Chimeric antigens for eliciting an immune response
|
US8025873B2
(en)
|
2002-06-20 |
2011-09-27 |
Paladin Labs, Inc. |
Chimeric antigens for eliciting an immune response
|
AU2003297583B2
(en)
*
|
2002-11-26 |
2010-01-14 |
Biocon, Ltd |
Modified naturetic compounds, conjugates, and uses thereof
|
ITMI20030755A1
(it)
*
|
2003-04-11 |
2004-10-12 |
Bottega Verde S R L |
Peptidi e loro derivati quali inibitori di fenomeni degradativi e composizioni contenenti gli stessi.
|
WO2004099384A2
(en)
*
|
2003-05-02 |
2004-11-18 |
Sigma-Aldrich Co. |
Solid phase cell lysis and capture platform
|
JP4078247B2
(ja)
*
|
2003-05-02 |
2008-04-23 |
キヤノン株式会社 |
磁性体−生体物質複合体型構造体、磁性体に対して結合能を有するアミノ酸配列を有するペプチド断片及びその遺伝子、ならびに磁性体−生体物質複合体型構造体の製造方法
|
US20040224425A1
(en)
*
|
2003-05-08 |
2004-11-11 |
Gjerde Douglas T. |
Biomolecule open channel solid phase extraction systems and methods
|
US8007805B2
(en)
*
|
2003-08-08 |
2011-08-30 |
Paladin Labs, Inc. |
Chimeric antigens for breaking host tolerance to foreign antigens
|
US7187286B2
(en)
|
2004-03-19 |
2007-03-06 |
Applera Corporation |
Methods and systems for using RFID in biological field
|
WO2006026248A1
(en)
*
|
2004-08-25 |
2006-03-09 |
Sigma-Aldrich Co. |
Compositions and methods employing zwitterionic detergent combinations
|
US7294614B2
(en)
*
|
2004-10-12 |
2007-11-13 |
Clontech Laboratories, Inc. |
Phosphoprotein affinity resins and methods for making and using the same
|
US20100029911A1
(en)
*
|
2004-11-24 |
2010-02-04 |
Aplagen Gmbh |
Method For Solid-Phase Peptide Synthesis And Purification
|
JP2008525041A
(ja)
|
2004-12-22 |
2008-07-17 |
ジェネンテック・インコーポレーテッド |
可溶性多膜貫通型タンパク質の産生方法
|
WO2006076471A2
(en)
*
|
2005-01-12 |
2006-07-20 |
Nobex Corporation |
Bnp conjugates and methods of use
|
JP2006239661A
(ja)
*
|
2005-03-07 |
2006-09-14 |
Pentax Corp |
吸着剤、吸着剤の製造方法、吸着装置および吸着装置の製造方法
|
US7229769B2
(en)
*
|
2005-03-25 |
2007-06-12 |
Illumina, Inc. |
Compositions and methods for detecting protease activity
|
US7741053B2
(en)
*
|
2005-05-13 |
2010-06-22 |
Sigma-Aldrich Co. |
Processes for purification of recombinant proteins
|
US7265213B2
(en)
*
|
2005-07-28 |
2007-09-04 |
Kpl, Inc. |
Methodology of conjugating chelators to biomolecules
|
ZA200804078B
(en)
*
|
2005-10-13 |
2009-09-30 |
Virexx Medical Corp |
Chimeric hepatitis C virus antigens for eliciting an immune response
|
JP2009525749A
(ja)
*
|
2006-02-08 |
2009-07-16 |
ユーエスヴィー リミテッド |
組換えタンパク質の精製のためのアフィニティーポリペプチド
|
GB0604187D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Fusion Antibodies Ltd |
Peptide and uses thereof
|
WO2007120999A2
(en)
*
|
2006-03-06 |
2007-10-25 |
Bio-Rad Laboratories, Inc. |
Chelating monomers and polymers
|
EP1878739A1
(en)
*
|
2006-07-14 |
2008-01-16 |
LEK Pharmaceuticals D.D. |
One step IMAC (MCAC) purification of proteins
|
US20110053225A1
(en)
*
|
2008-01-24 |
2011-03-03 |
Ge Healthcare Bio-Sciences Ab |
Multifunctional tags
|
WO2009140408A2
(en)
|
2008-05-13 |
2009-11-19 |
University Of Kansas |
Metal abstraction peptide (map) tag and associated methods
|
NZ597804A
(en)
|
2009-07-24 |
2013-10-25 |
Immune Design Corp |
Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
|
BR112013020875A2
(pt)
|
2011-02-15 |
2019-09-24 |
Immune Design Corp |
método para indução de uma resposta imune específica para um imunógeno em um indivíduo.
|
JP6054942B2
(ja)
|
2011-04-08 |
2016-12-27 |
イミューン デザイン コーポレイション |
免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法
|
US10100092B2
(en)
|
2011-11-03 |
2018-10-16 |
Vca, Inc. |
Compositions and methods to detect various infectious organisms
|
AU2013237900B2
(en)
|
2012-03-30 |
2017-07-27 |
Immune Design Corp. |
Lentiviral vector particles having improved transduction efficiency for cells expressing DC- SIGN
|
HU230585B1
(hu)
|
2012-05-30 |
2017-01-30 |
Budapesti Műszaki és Gazdaságtudományi Egyetem |
Fehérjék megkötésére és elválasztására alkalmas lantanida fémionokkal komplexált hordozók
|
WO2013181461A2
(en)
|
2012-06-01 |
2013-12-05 |
University Of Kansas |
Metal abstraction peptide with superoxide dismutase activity
|
EA035259B1
(ru)
|
2014-02-14 |
2020-05-21 |
Иммьюн Дизайн Корп. |
Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции
|
JP2017522312A
(ja)
|
2014-07-15 |
2017-08-10 |
イミューン デザイン コーポレイション |
Tlr4アゴニストアジュバント及びレンチウイルスベクターを用いたプライム・ブーストレジメン
|
BR112018008911A2
(pt)
|
2015-11-09 |
2018-11-27 |
Immune Design Corp |
composições compreendendo vetores lentivirais que expressam il-12 e métodos de uso das mesmas
|
WO2017083356A1
(en)
|
2015-11-09 |
2017-05-18 |
Immune Design Corp. |
A retroviral vector for the administration and expression of replicon rna expressing heterologous nucleic acids
|
WO2019152563A1
(en)
|
2018-01-30 |
2019-08-08 |
Life Technologies Corporation |
Instruments, devices and consumables for use in a workflow of a smart molecular analysis system
|
EP3986465A1
(en)
|
2019-06-18 |
2022-04-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften E. V. |
Site-specific, kinetically inert conjugation of labels and/or carriers to target molecules such as his-tagged proteins via metal complex reagents
|
MX2022008772A
(es)
|
2020-01-14 |
2022-10-07 |
Synthekine Inc |
Ortologos de il2 y metodos de uso.
|
CA3190459A1
(en)
|
2020-08-05 |
2022-02-10 |
Synthekine, Inc. |
Gp130 binding molecules and methods of use
|
CA3190417A1
(en)
|
2020-08-05 |
2022-03-17 |
Synthekine, Inc. |
Compositions and methods related to receptor pairings
|
US20230295315A1
(en)
|
2020-08-05 |
2023-09-21 |
Synthekine, Inc |
IL10RB Binding Molecules and Methods of Use
|
CN117242088A
(zh)
|
2020-08-05 |
2023-12-15 |
辛德凯因股份有限公司 |
Il10受体结合分子和使用方法
|
WO2022031884A2
(en)
|
2020-08-05 |
2022-02-10 |
Synthekine, Inc. |
Il2rg binding molecules and methods of use
|
EP4192877A4
(en)
|
2020-08-05 |
2024-10-16 |
Synthekine Inc |
SYNTHETIC CYTOKINES IL2RB/IL2RG
|
AU2021320233A1
(en)
|
2020-08-05 |
2023-03-23 |
Synthekine, Inc. |
IL10Ra binding molecules and methods of use
|
EP4192490A1
(en)
|
2020-08-05 |
2023-06-14 |
Synthekine, Inc. |
IL27Ra BINDING MOLECULES AND METHODS OF USE
|
EP4192489A2
(en)
|
2020-08-05 |
2023-06-14 |
Synthekine, Inc. |
Il2rb binding molecules and methods of use
|
JP2024504923A
(ja)
|
2021-01-11 |
2024-02-02 |
シンセカイン インコーポレイテッド |
受容体ペア形成に関する組成物および方法
|
WO2023288283A2
(en)
|
2021-07-14 |
2023-01-19 |
Synthekine, Inc. |
Methods and compositions for use in cell therapy of neoplastic disease
|
WO2024086739A1
(en)
|
2022-10-20 |
2024-04-25 |
Synthekine, Inc. |
Methods and compositions of il12 muteins and il2 muteins
|